News & Updates

Show Multimedia Only

Middle-aged gout patients at higher risk of cancer, mortality

24 Sep 2021

The risks of cancer and all-cause and cancer mortality are higher among middle-aged patients with gout than the general population, reveals a study.

Middle-aged gout patients at higher risk of cancer, mortality

24 Sep 2021

Tofacitinib may promote HBV reactivation in certain RA patients

24 Sep 2021

Use of tofacitinib for rheumatoid arthritis (RA) may lead to reactivation of hepatitis B virus (HBV), especially among hepatitis B surface antigen-positive (HBsAg+) and HBsAg-negative/hepatitis B core antibody-positive (HBsAg–/HBcAb+) patients, according to a study from Taiwan.

Tofacitinib may promote HBV reactivation in certain RA patients

24 Sep 2021

Sedentary behaviour ups risk of functional limitation in adults with knee OA

23 Sep 2021

Being inactive (zero 10-min bouts/week in moderate-to-vigorous physical activity [MVPA]) is associated with a higher risk of developing functional limitation in adults with knee osteoarthritis (OA), regardless of sedentary category, a study has found.

Sedentary behaviour ups risk of functional limitation in adults with knee OA

23 Sep 2021

Does tocilizumab prevent relapse in patients with giant cell arteritis?

23 Sep 2021

Treatment with tocilizumab, an interleukin (IL)-6 receptor antagonist, is effective for corticosteroid sparing in patients with giant cell arteritis (GCA), suggests a study. However, tocilizumab allows for a prolonged remission in fewer than half of the patients following treatment discontinuation.

Does tocilizumab prevent relapse in patients with giant cell arteritis?

23 Sep 2021

Pooled analysis boosts guselkumab safety for psoriatic arthritis

23 Sep 2021 by

A pooled safety analysis of two phase III DISCOVER trials demonstrated the favourable safety profile of the novel interleukin(IL)-23p19-specific monoclonal antibody guselkumab through 1 year for psoriatic arthritis (PsA).

Pooled analysis boosts guselkumab safety for psoriatic arthritis

23 Sep 2021

Team rehab improves functional outcomes, body composition in inflammatory arthritis

22 Sep 2021

A team rehabilitation for 4 weeks confers benefits on body composition, level of physical functioning, activity, and cardiorespiratory fitness (CRF) for up to 12 months in patients with inflammatory arthritis (IA), a study has shown.

Team rehab improves functional outcomes, body composition in inflammatory arthritis

22 Sep 2021

Ketoprofen as good as diclofenac plasters for relieving aching knee

10 Sep 2021 by

Topical ketoprofen and diclofenac yield comparable analgesic effects in the treatment of pain in patients with knee osteoarthritis, with ketoprofen having a favourable safety profile, as shown in a phase III study.

Ketoprofen as good as diclofenac plasters for relieving aching knee

10 Sep 2021

Corticosteroid use before embryo transfer improves ART success in women with RA, IBD

31 Aug 2021

Among women with rheumatoid arthritis (RA) and/or inflammatory bowel disease (IBD) undergoing assisted reproductive technology (ART) procedures, embryo transfer at the blastocyst stage and corticosteroid use prior to ART appear to improve chances of a live birth, a study has found.

Corticosteroid use before embryo transfer improves ART success in women with RA, IBD

31 Aug 2021

Comorbidities in RA tied to higher healthcare spending, lower income, employment prospect

29 Aug 2021

In patients with rheumatoid arthritis (RA), comorbidities tend to result in higher annual healthcare expenditure, lower likelihood of employment, higher rates of absenteeism, and lower income, according to a study. Heart failure (HF), despite its lower prevalence, is associated with the highest incremental expenditure and lowest chance of employment compared with other common comorbid conditions.

Comorbidities in RA tied to higher healthcare spending, lower income, employment prospect

29 Aug 2021

Apremilast fails to deliver clinical benefits in active ankylosing spondylitis

29 Aug 2021

Use of apremilast does not provide any clinical benefit in patients with active ankylosing spondylitis (AS), but the safety and tolerability of this treatment are consistent with its known profile, reports a study.

Apremilast fails to deliver clinical benefits in active ankylosing spondylitis

29 Aug 2021

News & Updates

Showing Rheumatology articles

Showing

Specialty:

Middle-aged gout patients at higher risk of cancer, mortality

Middle-aged gout patients at higher risk of cancer, mortality

Tofacitinib may promote HBV reactivation in certain RA patients

Tofacitinib may promote HBV reactivation in certain RA patients

Sedentary behaviour ups risk of functional limitation in adults with knee OA

Sedentary behaviour ups risk of functional limitation in adults with knee OA

Does tocilizumab prevent relapse in patients with giant cell arteritis?

Does tocilizumab prevent relapse in patients with giant cell arteritis?

Pooled analysis boosts guselkumab safety for psoriatic arthritis

Pooled analysis boosts guselkumab safety for psoriatic arthritis

Team rehab improves functional outcomes, body composition in inflammatory arthritis

Team rehab improves functional outcomes, body composition in inflammatory arthritis

Ketoprofen as good as diclofenac plasters for relieving aching knee

Ketoprofen as good as diclofenac plasters for relieving aching knee

Corticosteroid use before embryo transfer improves ART success in women with RA, IBD

Corticosteroid use before embryo transfer improves ART success in women with RA, IBD

Comorbidities in RA tied to higher healthcare spending, lower income, employment prospect

Comorbidities in RA tied to higher healthcare spending, lower income, employment prospect

Apremilast fails to deliver clinical benefits in active ankylosing spondylitis

Apremilast fails to deliver clinical benefits in active ankylosing spondylitis